• These stocks are poised to benefit as coronavirus roils markets
    Yahoo Finance

    These stocks are poised to benefit as coronavirus roils markets

    The historic stock market rout may have a few hidden winners as the coronavirus crisis ricochets across the globe.

  • Intesa, UBI line up advisers to face off in takeover battle
    Reuters

    Intesa, UBI line up advisers to face off in takeover battle

    Intesa Sanpaolo said on Friday it had hired JP Morgan, Morgan Stanley, UBS and local broker Equita SIM to complete a team of advisers led by Mediobanca supporting Italy's biggest retail bank in its takeover offer of rival UBI Banca. Intesa this month unveiled a surprise 4.9 billion euro ($5.3 billion) bid for smaller peer UBI Banca , offering 1.7 new Intesa shares for each UBI share tendered to create the euro zone's seventh-largest banking group with a focus on asset management and insurance. Intesa worked on the offer, the biggest European banking deal since the global financial crisis, with Milanese merchant bank Mediobanca, which remains its sole M&A and lead financial adviser.

  • Is Stamps.com (STMP) Outperforming Other Retail-Wholesale Stocks This Year?
    Zacks

    Is Stamps.com (STMP) Outperforming Other Retail-Wholesale Stocks This Year?

    Is (STMP) Outperforming Other Retail-Wholesale Stocks This Year?

  • Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit
    Zacks

    Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit

    FDA accepts Glaxo (GSK) and Novartis' (NVS) sBLA. FDA gives approval to Lilly's (LLY) Trulicity for cardiovascular indication.

  • 4 Tech Stocks to Buy Amid Coronavirus-Led Dip
    Zacks

    4 Tech Stocks to Buy Amid Coronavirus-Led Dip

    Here we pick four tech stocks that are expected rebound once the impact of coronavirus cools down.

  • Why Stamps.com (STMP) Could Be Positioned for a Surge
    Zacks

    Why Stamps.com (STMP) Could Be Positioned for a Surge

    Stamps.com (STMP) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

  • Trade Alert: Thomas Ricks At Ovintiv Inc. (TSE:OVV), Has Just Spent US$325k Buying Shares
    Simply Wall St.

    Trade Alert: Thomas Ricks At Ovintiv Inc. (TSE:OVV), Has Just Spent US$325k Buying Shares

    Potential Ovintiv Inc. (TSE:OVV) shareholders may wish to note that insider Thomas Ricks recently bought CA$325k worth...

  • The Zacks Analyst Blog Highlights: Toll Brothers, D.R. Horton, PulteGroup, KB Home and Meritage Homes
    Zacks

    The Zacks Analyst Blog Highlights: Toll Brothers, D.R. Horton, PulteGroup, KB Home and Meritage Homes

    The Zacks Analyst Blog Highlights: Toll Brothers, D.R. Horton, PulteGroup, KB Home and Meritage Homes

  • Bloomberg

    Morgan Stanley Not Done With Acquisitions Post E*Trade, CFO Says

    (Bloomberg) -- Morgan Stanley isn’t ruling out more deals after its biggest acquisition in a decade.The bank will still look for smaller purchases that could build up its asset-management unit, Chief Financial Officer Jon Pruzan said at an investor conference Thursday. Wealth-management deals are likely “off the table for a while” as the firm seeks to complete its $13 billion purchase of E*Trade Financial Corp., he said.Morgan Stanley would be looking to snap up companies that could add products or new regions for its investment management unit, and isn’t interested in acquisitions in the firm’s investment banking and trading division, Pruzan said.The E*Trade deal has sparked discussion over whether it will kick off a long-predicted series of takeovers big enough to reshape the top of the U.S. financial industry. JPMorgan Chase & Co. said this week it will “aggressively” pursue mergers, while Goldman Sachs Group Inc.’s David Solomon said Thursday his firm doesn’t need to find an acquisition just because its closest rival did.To contact the reporter on this story: Michael J. Moore in New York at mmoore55@bloomberg.netTo contact the editors responsible for this story: Michael J. Moore at mmoore55@bloomberg.net, Daniel Taub, Steve DicksonFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Europe Stocks Enter Correction; SocGen Says Half-Way Into Slump
    Bloomberg

    Europe Stocks Enter Correction; SocGen Says Half-Way Into Slump

    (Bloomberg) -- A sell-off in European equities intensified, pushing the regional benchmark into a technical correction, as more companies warned that the coronavirus would hit profits, while cases of the epidemic outside China increased.The Stoxx Europe 600 Index dropped 3.8%, extending its slump from the record high on Feb. 19 to 10%. Anheuser-Busch InBev NV and Standard Chartered Plc were the latest companies to sound the alarm about the outbreak’s impact on earnings.Equities are plunging this week on fears about the outbreak’s impact on global growth and corporate earnings. The U.S. reported its first instance of coronavirus that doesn’t have ties to a known outbreak, while the World Health Organization noted there were more cases reported in countries other than China for the first time.Societe Generale SA strategists including Alain Bokobza and Frank Benzimra wrote in a note on Thursday that European equity markets remain vulnerable and are only halfway through the pull-back, with autos, oil, mining, luxury goods as well as travel and leisure among the most affected sectors.European equities have now wiped out all the sharp gains made since late October. The Stoxx 600, which now trades below its 200-day moving average, is on track for its worst week since the heat of the euro-area sovereign debt crisis in August 2011.“Given the recent volatility, fear is the dominant factor,” said Guillermo Hernandez Sampere, head of trading at asset manager MPPM EK. “In a very short period, we went from all-time high celebrations to panic mode. It’s too early to ‘buy the dip’ in my view and I expect investors to stay on the sidelines or increase cash.”Travel stocks tumbled yet again on Thursday, leading declines. The sector has plunged the most among industry groups since Feb. 19. AB InBev slid 11% to the lowest since 2012 after the world’s largest brewer forecast the steepest decline in quarterly profit in at least a decade due to the coronavirus. Standard Chartered slipped 3.6% after saying it will miss a key profitability target amid the outbreak.“Investors should minimize their exposure to industrial commodities, luxury goods and European airlines,” said Seema Shah, chief strategist at Principal Global Investors. “We also favor quality stocks, especially large companies. “Defensive sectors such as utilities, real estate and health care are likely to do well in the equity markets compared to the broader markets.”Other corporate news also added to market pessimism. WPP Plc tumbled 16% after forecasting a fourth year with no sales growth. Aston Martin Lagonda Global Holdings Plc fell 9% after saying sales will slump in the first half of the year, before an expected boost from the new DBX SUV in the second half.\--With assistance from Jan-Patrick Barnert and Ksenia Galouchko.To contact the reporter on this story: Namitha Jagadeesh in London at njagadeesh@bloomberg.netTo contact the editors responsible for this story: Blaise Robinson at brobinson58@bloomberg.net, John ViljoenFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • L Brands (LB) Beats on Q4 Earnings, Victoria's Secret a Drag
    Zacks

    L Brands (LB) Beats on Q4 Earnings, Victoria's Secret a Drag

    L Brands' (LB) Bath & Body Works brand put up a stellar show. Total sales for the segment rise 11% during the fourth quarter of fiscal 2019.

  • Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Rise Y/Y
    Zacks

    Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Rise Y/Y

    Bayer (BAYRY) beats earnings estimates in the fourth quarter of 2019.

  • New Strong Buy Stocks for February 27th
    Zacks

    New Strong Buy Stocks for February 27th

    New Strong Buy Stocks for February 27th

  • Top Ranked Growth Stocks to Buy for February 27th
    Zacks

    Top Ranked Growth Stocks to Buy for February 27th

    Top Ranked Growth Stocks to Buy for February 27th

  • Essential (WTRG) Q4 Earnings Miss, Sales Meet Estimates
    Zacks

    Essential (WTRG) Q4 Earnings Miss, Sales Meet Estimates

    Essential Utilities' (WTRG) fourth-quarter revenues meet estimates and improve year over year, courtesy of rate increases and customer growth.

  • SINA Corp.'s (SINA) Q4 Earnings and Revenues Increase Y/Y
    Zacks

    SINA Corp.'s (SINA) Q4 Earnings and Revenues Increase Y/Y

    SINA Corp.'s (SINA) fourth-quarter top line reflects growth in non-advertising revenues, driven by the company's fin-tech businesses.

  • Aqua America (WTRG) Lags Q4 Earnings Estimates
    Zacks

    Aqua America (WTRG) Lags Q4 Earnings Estimates

    Aqua America (WTRG) delivered earnings and revenue surprises of -2.86% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • L Brands (LB) Q4 Earnings Beat Estimates
    Zacks

    L Brands (LB) Q4 Earnings Beat Estimates

    L Brands (LB) delivered earnings and revenue surprises of 1.08% and -0.05%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Juniper (JNPR) Down 2.6% Since Last Earnings Report: Can It Rebound?
    Zacks

    Juniper (JNPR) Down 2.6% Since Last Earnings Report: Can It Rebound?

    Juniper (JNPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • The Zacks Analyst Blog Highlights: Johnson & Johnson, Morgan Stanley, Sinopec, American Electric Power and Kinder Morgan
    Zacks

    The Zacks Analyst Blog Highlights: Johnson & Johnson, Morgan Stanley, Sinopec, American Electric Power and Kinder Morgan

    The Zacks Analyst Blog Highlights: Johnson & Johnson, Morgan Stanley, Sinopec, American Electric Power and Kinder Morgan

  • Physicians Realty Trust (DOC) Q4 FFO Match Estimates
    Zacks

    Physicians Realty Trust (DOC) Q4 FFO Match Estimates

    Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0.00% and -1.88%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Boasting A 27% Return On Equity, Is Weibo Corporation (NASDAQ:WB) A Top Quality Stock?
    Simply Wall St.

    Boasting A 27% Return On Equity, Is Weibo Corporation (NASDAQ:WB) A Top Quality Stock?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Rio Tinto Is Digging Mostly Into Its Pocket
    Bloomberg

    Rio Tinto Is Digging Mostly Into Its Pocket

    (Bloomberg Opinion) -- A combination of hefty dividends and contracting output is turning the world’s second-largest miner into the poster child for a $1.5 trillion industry’s growth quandary.Rio Tinto Group announced a record $3.7 billion final dividend Wednesday, adding to $11.9 billion of cash returns already paid in 2019. Yet it produced less iron ore, copper and aluminum, leaving market prices to lift underlying earnings by 18%. Rio’s Pilbara operations stumbled early in the year. Its Mongolian copper mine, a key source of future production and the basis of a greener portfolio, is now not only sorely overdue and over-budget, but also tangled in international tax arbitration. The $86 billion mining giant isn’t alone. High dividend yields and pedestrian output have begun to define resources heavyweights that used to be known for the exact opposite. Diversified groups relied on their varied sources of cash to expand, but large-scale opportunities are scarcer than ever, and portfolios look far less diverse too, once coal and other less appealing assets have been carved off. At Rio, iron ore now accounts for three-quarters of its underlying Ebitda.For investors, it hasn’t been all bad news. Since Chief Executive Officer Jean-Sebastien Jacques took the helm in 2016, Rio’s total return including reinvested dividends adds up to an impressive 112%, outpacing most rivals.Yet much of that is due to generous payouts. For a company that digs stuff up for a living, this may not be sustainable — especially for one that aims to build a portfolio better aligned with a carbon-light global economy. It may also be an indication of just how hard it is to change. Rio paid shareholders in 2019 more than double its capital expenditure budget for the same year.One priority has been copper. Under Jacques, head of that unit until he became CEO, Rio has said it wants to add more of the red metal as its existing mines age, and will look at other green ingredients, those for rechargeable batteries and the like. Yet a unit set up to consider just such deals hasn’t sealed a single one despite considering more than 200 opportunities, and the company has suffered blow after blow in Mongolia. Its Oyu Tolgoi mine in the South Gobi accounts for only a fraction of Rio’s value today, but could dictate the company’s fortunes. So far, it’s mostly an unhelpful headache. The mine, which Rio holds through Canada-listed Turquoise Hill Resources Ltd., is one of the largest copper deposits around, and could produce an annual 550,000 metric tons of copper, almost as much as Rio produced last year, plus 450,000 ounces of gold. In the parlance of big miners, it moves the needle.Unfortunately, it also encapsulates everything that makes such projects so challenging: tough geography, messy local politics and complex geology. The cost of the largest, underground, portion has swelled to as much as $7.2 billion, and could rise again when a final estimate is published later in 2020. First production may now be be 30 months later than predicted. Fears of a cash call have dragged down Turquoise Hill shares.In the latest development, Rio announced last week it would begin arbitration proceedings to solve a tax dispute. Few arbitration deals yield significant victories —  ask Barrick Gold Corp. and Antofagasta Plc, which won a $5.8 billion ruling against Pakistan last year — and  they tend to irk host governments, so it’s a worrying sign. The risk is that Oyu Tolgoi becomes Rio Tinto’s own version of Freeport-McMoRan Inc.’s Indonesian pride and joy, Grasberg – wonderful in theory, nearly impossible in practice.Rio won’t drop Mongolia, and not just because of Jacques’ own attachment to the project. A copper option, however long-dated, is valuable, even if the company doesn’t yet jump in to buy out Turquoise Hill minority shareholders.But what then? Rio has manageable debt and ample cash — $9.2 billion in free cash flow in 2019, the highest level in almost a decade — and deals look cheaper as shares in copper-heavy Freeport and First Quantum Minerals Ltd. have roughly halved since 2018. Perhaps, though, not cheap enough to warrant wrestling with Freeport’s U.S. liabilities or First Quantum’s Zambian operations.Rio isn’t shrinking quite yet. It has exploration projects, and iron-ore production already did better in the second half, albeit still short of the company’s ultimate target. Yet with Oyu Tolgoi mired in arbitration and geological complexities, and the economy swiftly shifting, it might be time for Rio to consider just how creative it can get.To contact the author of this story: Clara Ferreira Marques at cferreirama@bloomberg.netTo contact the editor responsible for this story: Matthew Brooker at mbrooker1@bloomberg.netThis column does not necessarily reflect the opinion of Bloomberg LP and its owners.Clara Ferreira Marques is a Bloomberg Opinion columnist covering commodities and environmental, social and governance issues. Previously, she was an associate editor for Reuters Breakingviews, and editor and correspondent for Reuters in Singapore, India, the U.K., Italy and Russia.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Top Research Reports for Johnson & Johnson, Morgan Stanley & Sinopec
    Zacks

    Top Research Reports for Johnson & Johnson, Morgan Stanley & Sinopec

    Top Research Reports for Johnson & Johnson, Morgan Stanley & Sinopec

  • Earnings Estimates Moving Higher for Stamps.com (STMP): Time to Buy?
    Zacks

    Earnings Estimates Moving Higher for Stamps.com (STMP): Time to Buy?

    Stamps.com (STMP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more